3,642
Views
9
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Paper

Knowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: A cross-sectional study

, , , , ORCID Icon, , & ORCID Icon show all
Article: 2073752 | Received 07 Jan 2022, Accepted 28 Apr 2022, Published online: 27 May 2022

References

  • Blair RJ. Varicella Zoster virus. Pediatr Rev. 2019;40:375–7. doi:10.1542/pir.2017-0242.
  • Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013;369:255–63. doi:10.1056/NEJMcp1302674.
  • Freer G, Pistello M. Varicella-Zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiologica. 2018;41(2):95–105.
  • Schmader K. Herpes Zoster. Clin Geriatr Med. 2016;32:539–53. doi:10.1016/j.cger.2016.02.011.
  • Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017;76:958–72.e2. doi:10.1016/j.jaad.2016.12.043.
  • Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis. 2015;15:1–5. doi:10.1186/s12879-015-1262-8.
  • Babamahmoodi F, Alikhani A, Ahangarkani F, Delavarian L, Barani H, Babamahmoodi A. Clinical manifestations of herpes zoster, its comorbidities, and its complications in North of Iran from 2007 to 2013. Neurol Res Int. 2015;2015:10–13. doi:10.1155/2015/896098.
  • Johnson RW, Alvarez-Pasquin M-J, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel J-P, Naldi L, Sanmarti LS, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3:109–20. doi:10.1177/2051013615599151.
  • Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W. The impact of varicella vaccination on the incidence of varicella and Herpes Zoster in the United States: updated evidence from observational databases, 1991-2016. Clin Infect Dis. 2020;70:995–1002. doi:10.1093/cid/ciz305.
  • Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang S-J, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older Adults. N Engl J Med. 2015;372:2087–96. doi:10.1056/nejmoa1501184.
  • Pickering G, Gavazzi G, Gaillat J, Paccalin M, Bloch K, Bouhassira D. Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study. BMJ Open. 2016;6:1–8. doi:10.1136/bmjopen-2015-009689.
  • Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez-Domingo J, Lal H, Andrews C, Athan E, et al. Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older. Journals Gerontol - Ser a Biol Sci Med Sci. 2019;74:1231–38. doi:10.1093/gerona/gly150.
  • Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 2018;84:251–62. doi:10.4103/ijdvl.IJDVL_1021_16.
  • Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, MacIntyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009;27:520–29. doi:10.1016/j.vaccine.2008.11.012.
  • Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Vaccination in the elderly: the challenge of immune changes with aging. Semin Immunol. 2018;40:83–94. doi:10.1016/j.smim.2018.10.010.
  • Koff WC, Schenkelberg T. The future of vaccine development. Vaccine. 2020;38:4485–86. doi:10.1016/j.vaccine.2019.07.101.
  • Martinez M, Shukla H, Nikulin J, Mbaeyi C, Jorba J, Ehrhardt D. Progress toward poliomyelitis eradication — Afghanistan, January 2018–may 2019. MMWR Morb Mortal Wkly Rep. 2019;68:729–33. doi:10.15585/mmwr.mm6833a4.
  • Rosamilia LL. Herpes Zoster presentation, management, and prevention: a modern case-based review. Am J Clin Dermatol. 2020;21:97–107. doi:10.1007/s40257-019-00483-1.
  • James SF, Chahine EB, Sucher AJ, Hanna CS. The new adjuvanted recombinant Herpes Zoster vaccine. Ann Pharmacother. 2018;52:673–80. doi:10.1177/1060028018758431.
  • John AR, Canaday DH. Herpes Zoster in the older adult. Infect Dis Clin North Am. 2017;31:811–26. doi:10.1016/j.idc.2017.07.016.
  • Macfarlane SBJ. Conducting a descriptive survey: 2. choosing a sampling strategy. Trop Doct. 1997;27:14–21. doi:10.1177/004947559702700108.
  • Lam ACY, Chan MY, Chou HY, Ho SY, Li HL, Lo CY, Shek KF, To SY, Yam KK, Yeung I. A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting. Hong Kong Med J. 2017;23:365–73. doi:10.12809/hkmj165043.
  • Yang TU, Cheong HJ, Song JY, Noh JY, Kim WJ. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Hum Vaccines Immunother. 2015;11:719–26. doi:10.1080/21645515.2015.1008885.
  • Baalbaki NA, Fava JP, Ng M, Okorafor E, Nawaz A, Chiu W, Salim A, Cha R, Kilgore PE. A community-based survey to assess knowledge, attitudes, beliefs and practices regarding Herpes Zoster in an urban setting. Infect Dis Ther. 2019;8:687–94. doi:10.1007/s40121-019-00269-2.
  • Lee TJ, Hayes S, Cummings DM, Cao Q, Carpenter K, Heim L, Edwards H. Herpes zoster knowledge, prevalence, vaccination rate by race. J Am Board Fam Med. 2013;26:45–51. doi:10.3122/jabfm.2013.01.120154.
  • Record flu vaccines in 2020 to protect Australians | health portfolio ministers. [Accessed 2021 July 12]. https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/record-flu-vaccines-in-2020-to-protect-australians.
  • Bachtiger P, Adamson A, Chow JJ, Sisodia R, Quint JK, Peters NS. The impact of the COVID-19 pandemic on the uptake of influenza vaccine: UK-wide observational study. JMIR Public Heal Surveill. 2021:7. doi:10.2196/26734.